KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Oncogene

• Publication date

  2014-04-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2014.49PMID 24704824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA‐26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin‐6‐Stat3 pathway

  2013cited by this paper
• miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2

  2013cited by this paper
• The tumor suppressor CDKN3 controls mitosis

  2013cited by this paper
• Signaling determinants of glioma cell invasion.

  2013cited by this paper
• Advances and challenges in the treatment of glioblastoma: a clinician's perspective.

  2013cited by this paper
• Characteristic Features of Stem Cells in Glioblastomas: From Cellular Biology to Genetics

  2012cited by this paper
• Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth

  2012cited by this paper
• MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.

  2012cited by this paper
• A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs.

  2011cited by this paper
• BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.

  2011cited by this paper
• Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship

  2010cited by this paper
• SNAI2/Slug promotes growth and invasion in human gliomas

  2010cited by this paper
• Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis.

  2010cited by this paper
• The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo.

  2009cited by this paper
• The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility

  2008cited by this paper
• Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component.

  2008cited by this paper
• Effects of Combined Therapy With a Rho-Kinase Inhibitor and Prostacyclin on Monocrotaline-Induced Pulmonary Hypertension in Rats

  2007cited by this paper
• Cdc2-mediated Schwann cell migration during peripheral nerve regeneration

  2007cited by this paper
• Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma.

  2007cited by this paper
• Proteomic screen defines the Polo‐box domain interactome and identifies Rock2 as a Plk1 substrate

  2007cited by this paper
• Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil.

  2006cited by this paper
• Interaction between ROCK II and Nucleophosmin/B23 in the Regulation of Centrosome Duplication

  2006cited by this paper
• Cdk2 and Cdk4 cooperatively control the expression of Cdc2

  2006cited by this paper
• The Structure of Dimeric ROCK I Reveals the Mechanism for Ligand Selectivity*

  2006cited by this paper
• Cdc42–MRCK and Rho–ROCK signalling cooperate in myosin phosphorylation and cell invasion

  2005cited by this paper
• The Rho kinases I and II regulate different aspects of myosin II activity

  2005cited by this paper
• The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo.

  2005cited by this paper
• Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.

  2005cited by this paper
• Cyclin A correlates with carcinogenesis and metastasis, and p27(kip1) correlates with lymphatic invasion, in colorectal neoplasms.

  2002cited by this paper
• Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma.

  2001cited by this paper
• Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.

  2000cited by this paper
• Advances in Brief Aberrant Transcripts of the Cyclin-dependent Kinase-associated Protein Phosphatase in Hepatocellular Carcinoma 1

  2000cited by this paper
• Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression

  2000cited by this paper
• The COOH Terminus of Rho-kinase Negatively Regulates Rho-kinase Activity*

  1999cited by this paper
• Integration of Rac-dependent Regulation of Cyclin D1 Transcription through a Nuclear Factor-κB-dependent Pathway*

  1999cited by this paper
• Phosphorylation and activation of smooth muscle myosin light chain kinase by MAP kinase and cyclin-dependent kinase-1.

  1996cited by this paper
• KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases.

  1994cited by this paper
• Phosphorylation of myosin-II regulatory light chain by cyclin-p34cdc2: a mechanism for the timing of cytokinesis

  1992cited by this paper

• The cancer-induced lactate load and oncologic remodeling hypothesis: lactate as a driver of biosynthesis and epigenetics in cancer

  2025cites this paper
• MiR-192–5p targets cell cycle regulation in diabetic kidney disease via cyclin-dependent kinase inhibitor 3

  2024cites this paper
• The role of Cyclin Dependent Kinase Inhibitor 3 (CDKN3) in promoting human tumors: Literature review and pan-cancer analysis

  2024cites this paper
• Targeting CDK1 in cancer: mechanisms and implications

  2023cites this paper
• Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin

  2023cites this paper
• The multifaceted mechanisms of malignant glioblastoma progression and clinical implications

  2022cites this paper
• Protein phosphorylation: A potential target in glioma development

  2022cites this paper
• Cellular reprogramming of diabetic foot ulcer fibroblasts triggers pro‐healing miRNA‐mediated epigenetic signature

  2021cites this paper
• Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis

  2021influential citation
• MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT

  2020cites this paper
• A Bioinformatics-Based Screening and Analysis of Key Genes in Hepatocellular Carcinoma

  2020cites this paper
• Identification of Key Genes and Signaling Pathways Associated with the Progression of Glioblastoma multiform

  2020influential citation
• Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?

  2020cites this paper
• ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1

  2019cites this paper
• Protein Phosphatases—A Touchy Enemy in the Battle Against Glioblastomas: A Review

  2019cites this paper
• Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma

  2019cites this paper
• The cyclin‐dependent kinase 2 (CDK2) mediates hematopoiesis through G1‐to–S transition in Chinese mitten crab Eriocheir sinensis

  2018cites this paper
• Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification.

  2017cites this paper
• Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway

  2017cites this paper
• Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome

  2017cites this paper
• Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.

  2017cites this paper
• Novel Insights into the Roles of Rho Kinase in Cancer

  2016cites this paper
• Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma

  2016cites this paper
• Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

  2016cites this paper
• CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma

  2016cites this paper
• ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho‐GSK3β/β‐catenin signaling

  2015cites this paper
• A Critical Role of CDKN3 in Bcr-Abl-Mediated Tumorigenesis

  2014cites this paper
• Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation.

  2014cites this paper